Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection

World Journal of Gastroenterology

Volumn 20, Issue 20, 2014, Pages 6226-6235

  Tunçbilek, Semra ^a  

^a UFUK UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis; Cytokine; Hepatitis B virus; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ESTROGEN RECEPTOR; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 28; INTERLEUKIN 28B; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MANNOSE BINDING LECTIN; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CELL PROLIFERATION; CHRONIC HEPATITIS; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DNA POLYMORPHISM; DNA REPLICATION; END STAGE LIVER DISEASE; GENE THERAPY; GENETIC ANALYSIS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUMOR GROWTH; VIRUS LOAD; ALLELE; COMPLICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEPATITIS B VIRUS; INFLAMMATION; LIVER TUMOR; METABOLISM; RISK FACTOR;

ALLELES; CARCINOMA, HEPATOCELLULAR; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFLAMMATION; LIVER NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN D;

EID: 84901506489     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i20.6226     Document Type: Article

References (100)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60 [PMID: 7612225 DOI: 10.1146/annurev.iy.13.040195.000333]
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745 [PMID: 9392700 DOI: 10.1056/NEJM199712113372406]
3. World Health Organization. Hepatitis B. Fact Sheet No 204. July 2013. Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/ Accessed on September 23, 2013
4. World Health Organization. Global Alert and Response (GAR). Hepatitis B. Available from: URL: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index1.html Accessed on September 23, 2013
5. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9: 641-644 [PMID: 12679901]
6. Park W, Keeffe EB. Diagnosis and treatment of chronic hepatitis B. Minerva Gastroenterol Dietol 2004; 50: 289-303 [PMID: 15788985]
7. Thursz M. Genetic susceptibility in infectious diseases. Biotechnol Genet Eng Rev 2000; 17: 253-264 [PMID: 11255668 DOI: 10.1080/02648725.2000.10647994]
8. Thursz M, Yee L, Khakoo S. Understanding the host genetics of chronic hepatitis B and C. Semin Liver Dis 2011; 31: 115-127 [PMID: 21538279 DOI: 10.1055/s-0031-1276642]
9. Grünhage F, Nattermann J. Viral hepatitis: human genes that limit infection. Best Pract Res Clin Gastroenterol 2010; 24: 709-723 [PMID: 20955972 DOI: 10.1016/j.bpg.2010.07.009]
10. McNicholl JM, Downer MV, Udhayakumar V, Alper CA, Swerdlow DL. Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera. Annu Rev Public Health 2000; 21: 15-46 [PMID: 10884944 DOI: 10.1146/annurev.publ-health.21.1.15]
11. Thursz MR. Host genetic factors influencing the outcome of epatitis. J Viral Hepat 1997; 4: 215-220 [PMID: 9278218 DOI: 10.1046/j.1365-2893.1997.00052.x]
12. Mackay IR. Genetic susceptibility to chronic hepatitis B virus infection. J Gastroenterol Hepatol 2006; 21: 1087-1088 [PMID: 16824056 DOI: 10.1111/j.1440-1746.2006.04430.x]
13. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9: 737-741 [PMID: 2764519]
14. de Andrade DR, de Andrade DR. The influence of the human genome on chronic viral hepatitis outcome. Rev Inst Med Trop Sao Paulo 2004; 46: 119-126 [PMID: 15286811]
15. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147 [PMID: 8630372]
16. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-384 [PMID: 8188271 DOI: 10.1006/ geno.1994.1076]
17. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803 [PMID: 12454835 DOI: 10.1053/gast.2002.37043]
18. Zhang PA, Li Y, Xu P, Wu JM. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J Gastroenterol 2004; 10: 1826-1829 [PMID: 15188516]
19. Rahman MA, Dhar DK, Yamaguchi E, Maruyama S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H, Nagasue N. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 2001; 7: 1325-1332 [PMID: 11350902]
20. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 2006; 12: 776-779 [PMID: 16521194]
21. Kim SS, Cheong JY, Lee D, Lee SK, Kim MH, Kwack K, Yang SJ, Lee HY, Cho SW. Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection. Hepatogastroenterology 2012; 59: 190-197 [PMID: 22251538]
22. Fontanini E, Cussigh A, Fabris C, Falleti E, Toniutto P, Bitetto D, Cmet S, Fumolo E, Fornasiere E, Bignulin S, Pinato DJ, Minisini R, Pirisi M. Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease. Inflammation 2010; 33: 251-258 [PMID: 20087638 DOI: 10.1007/ s10753-009-9179-2]
23. Song W, Zhang F, Li Z. A quantitative analysis of IL-6 mRNA expression of peripheral blood monocyte cell in patients with chronic hepatitis B. Zhonghua Ganzangbing Zazhi 2000; 8: 346-347 [PMID: 11135692]
24. Park BL, Lee HS, Kim YJ, Kim JY, Jung JH, Kim LH, Shin HD. Association between interleukin 6 promoter variants and chronic hepatitis B progression. Exp Mol Med 2003; 35: 76-82 [PMID: 12754410 DOI: 10.1038/emm.2003.11]
25. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-150 [PMID: 12526950 DOI: 10.1111/ j.1572-0241.2003.07179.x]
26. Giannitrapani L, Soresi M, Balasus D, Licata A, Montalto G. Genetic association of interleukin-6 polymorphism (-174 G/ C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol 2013; 19: 2449-2455 [PMID: 23674845 DOI: 10.3748/wjg.v19.i16.2449]
27. Wei YS, Lan Y, Tang RG, Xu QQ, Huang Y, Nong HB, Huang WT. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 2007; 125: 309-317 [PMID: 17720627 DOI: 10.1016/j.clim.2007.07.010]
28. Qin X, Deng Y, Liao XC, Mo CJ, Li X, Wu HL, He YN, Huang XM, Peng T, Chen ZP, Li S. The IL-8 gene polymorphisms and the risk of the hepatitis B virus/infected patients. DNA Cell Biol 2012; 31: 1125-1130 [PMID: 22335768 DOI: 10.1089/ dna.2011.1438]
29. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166: 5530-5539 [PMID: 11313392]
30. Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, Gu XH, Fei LE, Dong ZQ. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 2005; 118: 1604-1609 [PMID: 16232344]
31. Wu JF, Ni YH, Lin YT, Lee TJ, Hsu SH, Chen HL, Tsuei DJ, Hsu HY, Chang MH. Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. J Pediatr 2011; 158: 808-813 [PMID: 21168854 DOI: 10.1016/ j.jpeds.2010.11.015]
32. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, Kim YJ, Lee HS. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 12: 901-906 [PMID: 12668613 DOI: 10.1093/hmg/ ddg104]
33. Tseng LH, Lin MT, Shau WY, Lin WC, Chang FY, Chien KL, Hansen JA, Chen DS, Chen PJ. Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 2006; 67: 127-133 [PMID: 16441483 DOI: 10.1111/j.1399-0039.2006.00536.x]
34. Wang J, Ni H, Chen L, Song WQ. Interleukin-10 promoter polymorphisms in patients with hepatitis B virus infection or hepatocellular carcinoma in Chinese Han ethnic population. Hepatobiliary Pancreat Dis Int 2006; 5: 60-64 [PMID: 16481285]
35. Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, Ge R, Mei Y, Shen BB, Duan ZH, Li X. A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection 2011; 39: 21-27 [PMID: 21246248 DOI: 10.1007/ s15010-010-0075-3]
36. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol 2006; 21: 1163-1169 [PMID: 16824070 DOI: 10.1111/ j.1440-1746.2006.04304.x]
37. Li C, Zhi-Xin C, Li-Juan Z, Chen P, Xiao-Zhong W. The association between cytokine gene polymorphisms and the outcomes of chronic HBV infection. Hepatol Res 2006; 36: 158-166 [PMID: 16931134 DOI: 10.1016/j.hepres.2006.07.007]
38. Cho O, Cheong JY, Jun KJ, Kim SS, Chwae YJ, Kim K, Park S, Cho SW. Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22. Hepatol Int 2013; 7: 111-118 [PMID: 23519428 DOI: 10.1007/s12072-012-9361-8]
39. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999; 162: 5070-5077 [PMID: 10227975]
40. Cheong JY, Cho SW, Oh B, Kimm K, Lee KM, Shin SJ, Lee JA, Park BL, Cheong HS, Shin HD, Cho BY, Kim JH. Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance. Dig Dis Sci 2010; 55: 1113-1119 [PMID: 19466545 DOI: 10.1007/s10620-009-0819-z]
41. Sun Y, Chen HY, Wang F, Zhang X, Jiang HQ, Shao FJ, Zhu SH. [Effect of IL-18 on peripheral blood monocytes from chronic hepatitis B patients]. Zhonghua Ganzangbing Zazhi 2003; 11: 470-473 [PMID: 12939178]
42. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152 [PMID: 11108943 DOI: 10.1016/ S0165-5728(00)00407-0]
43. Zhang PA, Wu JM, Li Y, Yang XS. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005; 11: 1594-1598 [PMID: 15786533]
44. Migita K, Sawakami-Kobayashi K, Maeda Y, Nakao K, Kondoh S, Sugiura M, Kawasumi R, Segawa O, Tajima H, Machida M, Nakamura M, Yano K, Abiru S, Kawasaki E, Yatsuhashi H, Eguchi K, Ishibashi H. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Transl Res 2009; 153: 91-96 [PMID: 19138654 DOI: 10.1016/j.trsl.2008.11.008]
45. Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005; 79: 3851-3854 [PMID: 15731279 DOI: 10.1128/JVI.79.6.3851-3854.2005]
46. Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int 2011; 31: 1118-1126 [PMID: 21745278 DOI: 10.1111/j.1478-3231.2011.02507.x]
47. Lampertico P, Viganò M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, De Francesco R, Colombo M. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology 2013; 57: 890-896 [PMID: 22473858 DOI: 10.1002/ hep.25749]
48. Li Y, Shi Y, Chen J, Cai B, Ying B, Wang L. Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population. Int J Immunogenet 2012; 39: 346-352 [PMID: 22325058 DOI: 10.1111/j.1744-313X.2012.01097.x]
49. Chen J, Li Y, Wang L, Fu Y, Liao Y, Zhang J. Association of three SNPs in interleukin-28B with graft hepatic dysfunction after liver transplantation in Chinese Han population. Gene 2012; 508: 121-124 [PMID: 22967712 DOI: 10.1016/ j.gene.2012.07.065]
50. Martín-Carbonero L, Rallón NI, Benito JM, Poveda E, González-Lahoz J, Soriano V. Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B? AIDS Res Hum Retroviruses 2012; 28: 1262-1264 [PMID: 22324878]
51. Peng LJ, Guo JS, Zhang Z, Shi H, Wang J, Wang JY. IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection. Tissue Antigens 2012; 79: 302-305 [PMID: 22239156 DOI: 10.1111/j.1399-0039.2011.01835.x]
52. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar- Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220 [PMID: 10358757 DOI: 10.1146/annurev.immunol.17.1.189]
53. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23: 17-23 [PMID: 8550037 DOI: 10.1002/hep.510230103]
54. Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sökmen M. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C. Int J Infect Dis 2013; 17: e44-e49 [PMID: 23040881 DOI: 10.1016/j.ijid.2012.08.004]
55. Conde SR, Feitosa RN, Freitas FB, Hermes RB, Demachki S, Araújo MT, Soares MC, Ishak R, Vallinoto AC. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B. Cytokine 2013; 61: 940-944 [PMID: 23395388 DOI: 10.1016/j.cyto.2013.01.004]
56. Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJ, Williams R. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12: 241-245 [PMID: 2051003 DOI: 10.1016/0168-8278(91)9094 5-8]
57. Zhang G, Li Z, Han Q, Li N, Zhu Q, Li F, Lv Y, Chen J, Lou S, Liu Z. Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection. Infect Genet Evol 2011; 11: 1624-1630 [PMID: 21712100 DOI: 10.1016/j.meegid.2011.06.004]
58. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999; 66: 562-566 [PMID: 10534109]
59. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560 [PMID: 8426126 DOI: 10.1084/jem.177.2.557]
60. Höhler T, Kruger A, Gerken G, Schneider PM, Meyerzum Büschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582 [PMID: 9528902 DOI: 10.1046/ j.1365-2249.1998.00534.x]
61. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, Gao JR, Gou CY, Li H. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol 2005; 11: 5213-5217 [PMID: 16127755]
62. Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect 2005; 11: 52-56 [PMID: 15649304 DOI: 10.1111/ j.1469-0691.2004.01029.x]
63. Niro GA, Fontana R, Gioffreda D, Valvano MR, Lacobellis A, Facciorusso D, Andriulli A. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 2005; 25: 1175-1181 [PMID: 16343069 DOI: 10.1111/j.1478-3231.2005.01166.x]
64. Somi MH, Najafi L, Noori BN, Alizadeh AH, Aghah MR, Shavakhi A, Ehsani MJ, Aghazadeh R, Masoodi M, Amini S, Baladast M, Zali MR. Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol 2006; 25: 14-15 [PMID: 16567888]
65. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005; 42: 505-510 [PMID: 15763337 DOI: 10.1016/j.jhep.2004.11.026]
66. Wang B, Wang J, Zheng Y, Zhou S, Zheng J, Wang F, Ma X, Zeng Z. A study of TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology 2010; 42: 674-680 [PMID: 21080879 DOI: 10.3109/00313025.2010.523696]
67. Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol 2008; 8: 20-25 [PMID: 17974504 DOI: 10.1016/ j.meegid.2007.09.001]
68. Qiu B, Wang X, Zhang P, Shi C, Zhang J, Qiu W, Wang W, Li D. Association of TNF-α promoter polymorphisms with the outcome of persistent HBV infection in a northeast Chinese Han population. Acta Biochim Biophys Sin (Shanghai) 2012; 44: 712-718 [PMID: 22695741 DOI: 10.1093/abbs/gms046]
69. Fletcher GJ, Samuel P, Christdas J, Gnanamony M, Ismail AM, Anantharam R, Eapen CE, Chacko MP, Daniel D, Kannangai R, Abraham P. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 2011; 12: 552-558 [PMID: 21593777 DOI: 10.1038/gene.2011.32]
70. Han Q, Duan S, Zhang G, Li Z, Li N, Zhu Q, Lv Y, Chen J, Liu Z. Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection. Inflamm Res 2011; 60: 1071-1078 [PMID: 21847627 DOI: 10.1007/s00011-011-0368-8]
71. Zheng MH, Xiao DD, Lin XF, Wu SJ, Peng MM, Yu XY, Liu WY, Li LF, Shi KQ, Fan YC, Chen YP. The tumour necrosis factor-α-238A allele increases the risk of chronic HBV infection in European populations. J Viral Hepat 2012; 19: e11-e17 [PMID: 22239507 DOI: 10.1111/j.1365-2893.2011.01491.x]
72. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14: 841-848 [PMID: 18070287]
73. Kao PC, Wu JF, Ni YH, Lin YT, Chen HL, Hsu SH, Hsu HY, Chang MH. Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int 2010; 30: 1448-1453 [PMID: 20825556 DOI: 10.1111/j.1478-3231.2010.02340.x]
74. Filik L. Tumour necrosis factor-α promoter region polymorphisms and spontaneous HBsAg clearance. Liver Int 2011; 31: 1062; authors reply 1062 [PMID: 21733098 DOI: 10.1111/ j.1478-3231.2011.02456.x]
75. Shi KQ, Cai XH, Xiao DD, Wu SJ, Peng MM, Lin XF, Liu WY, Fan YC, Chen YP, Zheng MH. Tumour necrosis factorα-857T allele reduces the risk of hepatitis B virus infection in an Asian population. J Viral Hepat 2012; 19: e66-e72 [PMID: 22239528 DOI: 10.1111/j.1365-2893.2011.01540.x]
76. Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, Chen YP. Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis 2010; 14: e580-e585 [PMID: 20004605 DOI: 10.1016/j.ijid.2009.08.010]
77. Xia Q, Zhou L, Liu D, Chen Z, Chen F. Relationship between TNF-a lt; alpha& gt; gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS One 2011; 6: e19606 [PMID: 21572952 DOI: 10.1371/journal. pone.0019606]
78. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86: 531-542 [PMID: 8752208 DOI: 10.1016/S0092-8674(00)80127-0]
79. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7: d793-d807 [PMID: 11897555 DOI: 10.2741/gressner]
80. Yang ZX, Wang H, Gao CF, Xu LL, Zhao WJ. [Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis]. Zhonghua Yixue Zazhi 2005; 85: 1021-1026 [PMID: 16029542]
81. Gupta V, Arora R, Saha A, Dhir A, Kar P, Bamezai R. Novel variations in the signal peptide region of transforming growth factor beta1 gene in patients with hepatitis: a brief report from India. Int J Immunogenet 2005; 32: 79-82 [PMID: 15787639 DOI: 10.1111/j.1744-313X.2005.00499.x]
82. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, Yoon JH, Kim CY, Kim MS, Kim JY, Jung JH, Kim LH, Park BL, Shin HD. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003; 35: 196-202 [PMID: 12858019 DOI: 10.1038/ emm.2003.27]
83. Yu SK, Kwon OS, Jung HS, Bae KS, Kwon KA, Kim YK, Kim YS, Kim JH. Influence of transforming growth factor- beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers. J Korean Med Sci 2010; 25: 564-569 [PMID: 20357999 DOI: 10.3346/ jkms.2010.25.4.564]
84. Long KZ, Santos JI. Vitamins and the regulation of the immune response. Pediatr Infect Dis J 1999; 18: 283-290 [PMID: 10093956 DOI: 10.1097/00006454-199903000-00018]
85. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724 [PMID: 9952386 DOI: 10.1086/314614]
86. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006; 44: 856-863 [PMID: 16545485 DOI: 10.1016/ S0168-8278(06)80033-4]
87. Apolinario A, Majano PL, Alvarez-Pérez E, Saez A, Lozano C, Vargas J, García-Monzón C. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002; 97: 2861-2870 [PMID: 12425561 DOI: 10.1111/j.1572-0241.2002.07054.x]
88. Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection]. Korean J Hepatol 2005; 11: 116-124 [PMID: 15980670]
89. Gong QM, Kong XF, Yang ZT, Xu J, Wang L, Li XH, Jin GD, Gao J, Zhang DH, Jiang JH, Lu ZM, Zhang XX. Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection. J Viral Hepat 2009; 16: 674-680 [PMID: 19714778 DOI: 10.1111/ j.1365-2893.2009.01130.x]
90. Lin YJ, Lan YC, Huang YC, Lin TH, Huang SM, Lai CC, Liu CS, Lin CW, Chen SY, Tsai FJ. Effects of cytokine and cytokine receptor gene variation on high anti-HB titers: following up on Taiwan's neonatal hepatitis B immunization program. Clin Chim Acta 2012; 413: 1194-1198 [PMID: 22484276 DOI: 10.1016/j.cca.2012.03.004]
91. Macedo LC, Isolani AP, Visentainer JE, Moliterno RA. Association of cytokine genetic polymorphisms with the humoral immune response to recombinant vaccine against HBV in infants. J Med Virol 2010; 82: 929-933 [PMID: 20419805 DOI: 10.1002/jmv.21762]
92. Pan L, Zhang W, Liang Z, Wu X, Zhu X, Li J, Li T, Wang L, Li H, Liu Y. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol 2012; 84: 26-33 [PMID: 22052597 DOI: 10.1002/ jmv.22251]
93. Chen J, Liang Z, Lu F, Fang X, Liu S, Zeng Y, Zhu F, Chen X, Shen T, Li J, Zhuang H. Toll-like receptors and cytokines/ cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011; 29: 706-711 [PMID: 21111021 DOI: 10.1016/j.vaccine.2010.11.023]
94. Wang Y, Xu P, Zhu D, Zhang S, Bi Y, Hu Y, Zhou YH. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine 2012; 30: 5708-5713 [PMID: 22824342 DOI: 10.1016/j.vaccine.2012.07.010]
95. Chatzidaki V, Choumerianou D, Dimitriou H, Kouroumalis E, Galanakis E. Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virus. Eur J Gastroenterol Hepatol 2012; 24: 1185-1190 [PMID: 22772094 DOI: 10.1097/MEG.0b013e328356440f]
96. Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 2012; 142: 513-520. e1 [PMID: 22108195 DOI: 10.1053/j.gastro.2011.11.025]
97. Daniels HM, Meager A, Eddleston AL, Alexander GJ, Williams R. Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet 1990; 335: 875-877 [PMID: 1969983 DOI: 10.1016/0140-6736(90)90475-K]
98. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat 1999; 6: 405-409 [PMID: 10607257 DOI: 10.1046/j.1365-2893.1999.00180.x]
99. Frodsham AJ, Zhang L, Dumpis U, Taib NA, Best S, Durham A, Hennig BJ, Hellier S, Knapp S, Wright M, Chiaramonte M, Bell JI, Graves M, Whittle HC, Thomas HC, Thursz MR, Hill AV. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci USA 2006; 103: 9148-9153 [PMID: 16757563 DOI: 10.1073/pnas.0602800103]
100. Center for Disease Control and Prevention. Hepatitis B, Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book: Course Textbook - 12th Edition Second Printing (May 2012). Available from: URL: http://www.cdc.gov/vaccines/pubs/pinkbook/hepb.html Accessed on September 23, 2013